Home › Acute Lymphoblastic Leukemia › Tennessee
Acute Lymphoblastic Leukemia clinical trials in Tennessee
22 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in Tennessee.
Cities in Tennessee
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy, Nashville
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
- St. Jude Children's Research Hospital, Memphis
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06819475Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated Aug 31, 2026 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated Aug 28, 2026 · NCT07257419The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- and 1 more
RecruitingPhase 1/2
Up to age 22 · All sexes · Updated Aug 25, 2026 · NCT04726241A Study of CTD402 in T-ALL/LBL Patients
- Sarah Cannon Research Insitute, Nashville
RecruitingPhase 1/2
Ages 1 and older · All sexes · Updated Aug 19, 2026 · NCT07070219Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
- St. Jude Children's Research Hospital, Memphis
Recruiting
Ages 20 to 50 · All sexes · Updated Aug 14, 2026 · NCT07191119Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
1 Day – 17 Years · All sexes · Updated Aug 14, 2026 · NCT06274788Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
- St. Jude Children's Research Hospital, Memphis
Recruiting
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT06747910Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Jul 16, 2026 · NCT06533748Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 4
Ages 1 to 18 · All sexes · Updated Jul 14, 2026 · NCT06289673Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Research Site, Franklin
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Jul 13, 2026 · NCT07109219A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- St. Jude Childrens Research Hospital, Memphis
- Vanderbilt University, Nashville
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT07228741Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1/2
Up to age 21 · All sexes · Updated Jun 3, 2026 · NCT04195347CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated May 19, 2026 · NCT06777979CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Up to age 21 · All sexes · Updated Mar 25, 2026 · NCT06847269A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- TriStar Centennial Medical Center, Nashville
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Mar 24, 2026 · NCT04988555CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated Jan 23, 2026 · NCT06326463Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Ages 10 to 30 · All sexes · Updated Dec 4, 2025 · NCT05194397HPC Offered for PRESERVE Expansion
- Tristar Centennial Medical Center, Nashville
RecruitingObservational study
Ages 12 to 80 · All sexes · Updated Aug 28, 2025 · NCT07145411Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.